Literature DB >> 29544082

Isolation and characterization of bacteriophages from India, with lytic activity against Mycobacterium tuberculosis.

Urmi Bajpai1,1, Abhishek Kumar Mehta1,1, Kandasamy Eniyan1,1, Avni Sinha1,1, Ankita Ray1,1, Simran Virdi1,1, Shazeb Ahmad1,1, Aridni Shah1,1, Deepanksha Arora1,1, Devyani Marwaha1,1, Gunjan Chauhan1,1, Prarthna Saraswat1,1, Punita Bathla1,1, Ruchi Singh1,1.   

Abstract

Bacteriophages are being considered as a promising natural resource for the development of alternative strategies against mycobacterial diseases, especially in the context of the wide-spread occurrence of drug resistance among the clinical isolates of Mycobacterium tuberculosis. However, there is not much information documented on mycobacteriophages from India. Here, we report the isolation of 17 mycobacteriophages using Mycobacterium smegmatis as the bacterial host, where 9 phages also lyse M. tuberculosis H37Rv. We present detailed analysis of one of these mycobacteriophages - PDRPv. Transmission electron microscopy and polymerase chain reaction analysis (of a conserved region within the TMP gene) show PDRPv to belong to the Siphoviridae family and B1 subcluster, respectively. The genome (69 110 bp) of PDRPv is circularly permuted double-stranded DNA with ∼66% GC content and has 106 open reading frames (ORFs). On the basis of sequence similarity and conserved domains, we have assigned function to 28 ORFs and have broadly categorized them into 6 groups that are related to replication and genome maintenance, DNA packaging, virion release, structural proteins, lysogeny-related genes and endolysins. The present study reports the occurrence of novel antimycobacterial phages in India and highlights their potential to contribute to our understanding of these phages and their gene products as potential antimicrobial agents.

Entities:  

Keywords:  B1 subcluster; M. tuberculosis; diversité des phages; mycobacteriophage; mycobactériophages; phage diversity; sous-groupe B1

Mesh:

Substances:

Year:  2018        PMID: 29544082     DOI: 10.1139/cjm-2017-0387

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  5 in total

1.  Complete Genome Sequence of Mycobacteriophage IgnatiusPatJac.

Authors:  Olivia Jacobs; Nikki Gentle; Christopher Ealand; Bavesh Kana
Journal:  Microbiol Resour Announc       Date:  2022-09-21

Review 2.  Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.

Authors:  Carlos Aranaga; Lady Daniela Pantoja; Edgar Andrés Martínez; Aura Falco
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

3.  Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review.

Authors:  Taher Azimi; Mehrdad Mosadegh; Mohammad Javad Nasiri; Sahar Sabour; Samira Karimaei; Ahmad Nasser
Journal:  Infect Drug Resist       Date:  2019-09-17       Impact factor: 4.003

Review 4.  Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis.

Authors:  Anna Allué-Guardia; Rajagopalan Saranathan; John Chan; Jordi B Torrelles
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 5.  A Review on Mycobacteriophages: From Classification to Applications.

Authors:  Sepideh Hosseiniporgham; Leonardo A Sechi
Journal:  Pathogens       Date:  2022-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.